{
    "code": "52027017",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52027017",
    "time": "2020-02-26 06:32:14",
    "許可證字號": "衛部藥輸字第027017號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "110\/12\/05",
    "發證日期": "105\/12\/05",
    "許可證種類": "原料藥",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "null",
    "中文品名": "&quot;阿威&quot;檸檬酸吩坦尼",
    "英文品名": "&quot;Arevipharma&quot; Fentanyl Citrate",
    "適應症": "麻醉性鎮痛藥",
    "劑型": "040（粉）",
    "包裝": "0.5公斤以上裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "01製劑原料",
    "管制藥品分類級別": "B第二級管制藥品",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "",
    "限制項目": "02輸　入 32第二級管制藥品",
    "申請商名稱": "6201180767  衛生福利部食品藥物管理署管制藥品製藥工廠",
    "申請商地址": "台北市南港區忠孝東路六段467號地下一層",
    "主製造廠": [
        {
            "製造廠名稱": "FDE0588000  AREVIPHARMA GMBH",
            "製造廠廠址": "MEISSNER STRASSE 35, 01445 RADEBEUL, GERMANY",
            "製造廠公司地址": "",
            "製造廠國別": "GERMANY",
            "製程": ""
        }
    ],
    "CCC號列": "29333300009 阿華吩坦尼（ＩＮＮ）、安尼勒立汀（ＩＮＮ）、培集屈密特（ＩＮＮ）、溴西泮（ＩＮＮ）、狄芬諾新（ＩＮＮ）、狄芬諾西萊（ＩＮＮ）、狄匹潘濃（ＩＮＮ）、吩坦尼（ＩＮＮ）、酚派丙酮（ＩＮＮ）、派醋甲酯（ＩＮＮ）、潘他唑新（ＩＮＮ）、配西汀（ＩＮＮ）、配西汀（ＩＮＮ）中間體、苯環利定（ＩＮＮ）（ＰＣＰ）、吩諾配立汀（ＩＮＮ）、派苯甲醇（ＩＮＮ）、匹立屈密特（ＩＮＮ）、普魯匹蘭（ＩＮＮ）及屈美配立汀（ＩＮＮ）；其鹽類Alfentanil (INN), anileridine (INN), bezitramide (INN), bromazepam (INN), difenoxin (INN), diphenoxylate (INN), dipipanone (INN), fentanyl (INN), ketobemidone (INN), methylphenidate (INN), pentazocine (INN), pethidine (INN), pethidine (INN) intermediate a, phencyclidine (INN) (pcp), phenoperidine (INN), pipradrol (INN), piritramide (INN), propiram (INN) and trimeperidine (INN); salts thereof",
    "藥理治療分類": "",
    "ingredients": [],
    "仿單外盒": [
        {
            "title": "Arevipharma_label_pdf-106-01-04.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027017&Seq=001&Type=8"
        }
    ]
}